** Shares of Sigma Healthcare SIG.AX fall as much as 7% to A$2.930, their lowest levels since April 9
** Stock logs its biggest intraday pct gain since mid-December 2024
** SIG among top worst performers in the benchmark index
** UBS retains "neutral" rating, needs more conviction in the retail pharmacy franchiser's international growth outlook
** Co says 9-month normalised EBIT (unaudited) growth for combined group, compared with pcp for Chemist Warehouse Group (CWG) broadly consistent with the 36% growth achieved by CWG for 1H FY25
** Sigma Healthcare completed merger with CWG on February 12
** Average rating of eight analysts is "hold", their median PT is A$2.80 – according to data compiled by LSEG
(Reporting by Sneha Kumar in Bengaluru)
((Sneha.kumar@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。